Stockholm, Sweden-based EQT Life Sciences secured €25M to invest in commercial-stage, de-risked medtech and digital health technologies across the life sciences sector.
10/30/2026
AP Ventures Fund III
London-based AP Ventures closed $300M Fund III to invest in early-stage...

